XASX
NVU
Market cap38mUSD
Oct 09, Last price
0.05AUD
1D
-3.92%
1Q
11.36%
IPO
-51.00%
Name
Nanoveu Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nanoveu Limited, an Australian technology company founded in 2018 and based in Subiaco, focuses on inventing and globally marketing nanotechnology-based solutions for consumer electronics. Its current offerings include Nanoshield, an antiviral protective layer that comes as mobile phone screen covers, cases, and a commercial film for diverse surface applications. Another key product, EyeFly3D, enables standard 2D digital displays to render content in 3D without requiring specialized glasses. Additionally, the company is actively developing several new ventures: Customskins vending machines designed for quick and accurate mobile phone screen cover application (taking just over a minute), EyeFyx, a vision correction system using a combination of hardware and software to modify screen output, and an anti-flamatory coating technology intended for plastic laminates within the aviation and transport industries.
Key people
David Pevcic
Non-Executive Independent Chairman of the Board · since 2024
Siyuan Chen
Chief Financial Officer, Director · since 2025
Alfred Chong
Chief Executive Officer, Managing Director · since 2021
Harry Spindler
Company Secretary · since 2025
Steven Apedaile
Independent Non-Executive Director · since 2018
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑10 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||